SBX — SynBiotic SE Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- €16.00m
- €17.30m
- €3.86m
Annual balance sheet for SynBiotic SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | GAS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | — | 5.99 | 3.2 | 0.967 | 0.089 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | 0.922 | 0.727 | 0.491 | 0.565 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.238 | 7.69 | 10.6 | 8.05 | 6.53 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 0.023 | 5.86 | 5.42 | 4.89 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 0.238 | 35 | 60.6 | 40.6 | 34.9 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | — | 9.21 | 4.74 | 5.74 | 8.02 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.003 | 9.54 | 25.6 | 18 | 19.1 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.236 | 25.5 | 35 | 22.6 | 15.8 |
Total Liabilities & Shareholders' Equity | 0.238 | 35 | 60.6 | 40.6 | 34.9 |
Total Common Shares Outstanding |